Global Blood Plasma Market - Analysis By Type (Immunoglobulins - IV+SC, Albumin, Factor VIII - Plasma Derived), By Region, By Country (2018 Edition): Opportunities and Forecast (2013-2023)
Table of Contents
1. Research Methodology
2. Executive Summary
3. Strategic Recommendations
4. Global Blood Plasma Market: Product Outlook
5. Global Blood Plasma Market: Growth and Forecast
5.1 By Value (2013-2017)
5.2 By Value (2018-2023)
5.3 By Company Share (2017)
6. Global Blood Plasma Market Size, By Type: Breakdown (%)
6.1 Global Immunoglobulins (IV+SC) Market
6.1.1 By Value (2013-2023)
6.1.2 By Volume (2013-2023)
6.1.3 By Company Share, 2017
6.2 Global Albumin Market
6.2.1By Value (2013-2023)
6.2.2 By Volume (2013-2023)
6.2.3 By Company Share, 2017
6.3 Global FVIII (pd) Market
6.3.1 By Value (2013-2023)
6.3.2 By Volume (2013-2023)
6.3.3 By Company Share, 2017
6.4 Global Other Plasma Product Market: By Value (2013-2023)
6.5 Global Blood Plasma Market: Market Comparison, By Segments
6.6 Global Blood Plasma Market: Market Attractiveness, By Segments
7. Global Blood Plasma Market: Regional Analysis
7.1 North America Blood Plasma Market: An Analysis
7.1.1 By Value (2013-2017)
7.1.2 By Value (2018-2023)
7.2 North America Blood Plasma Market: Country Analysis
7.2.1 U.S.A Blood Plasma Market, By Value (2013-2023)
7.2.2 Canada Blood Plasma Market, By Value (2013-2023)
7.3 Europe Blood Plasma Market: An Analysis
7.3.1 By Value (2013-2017)
7.3.2 By Value (2018-2023)
7.4 Europe Blood Plasma Market: Country Analysis
7.4.1 Germany Blood Plasma Market, By Value (2013-2023)
7.4.2 France Blood Plasma Market, By Value (2013-2023)
7.4.3 Italy Blood Plasma Market, By Value (2013-2023)
7.5 APAC Blood Plasma Market: An Analysis
7.5.1 China Blood Plasma Market, By Value (2013-2023)
7.5.2 Japan Blood Plasma Market, By Value (2013-2023)
7.5.3 India Blood Plasma Market, By Value (2013-2023)
7.5.4 Australia Blood Plasma Market, By Value (2013-2023)
7.5.5 South-East Asia Blood Plasma Market, By Value (2013-2023)
7.6 ROW Blood Plasma Market: An Analysis
7.6.1 By Value (2013-2017)
7.6.2 By Value (2013-2023)
7.7 Global Blood Plasma Market: Market Comparison, By Regions
7.8 Global Blood Plasma Market: Market Attractiveness, By Regions
8. Global Blood Plasma Market Dynamics
8.1 Drivers
8.2 Challenges
8.3 Trends
9. Blood Plasma Market: Policy and Regulatory Landscape
10. Global Blood Plasma Market: Supply Chain Analysis
11. Porter's Five Forces Analysis
12 Company Profiles
12.1 CSL Limited
12.2 Baxter International
12.3 Grifols S.A.
12.4 Octa Pharma
12.5 Emergent Bio-solutions
12.6 Antaris Pharma
12.7 AMAG Pharma
12.8 Kedrion Biota Pharma
12.9 Bio delivery Science International
12.10 Biotest A.G.
List of Figures
Figure 1: Plasma Proteins and Diseases They Treat
Figure 2: Global Blood Plasma Market Size, By Value, 2013-2017 (USD Billion)
Figure 3: IVIG Consumption, By Selected Countries, 2015, (Kg/million population)
Figure 4: Endocrine, Metabolic, Blood and Immune Disorders, DALYs Per Million, Both Sexes, All ages, 2016
Figure 5: United States Blood Plasma Collection, 2013-2016, in Million Liters
Figure 6: Number of Blood Collection Centers in United States, 2013-2016
Figure 7: United States Healthcare Expenditure, 2013-2016
Figure 8: United States Blood Plasma Export to World, 2013-2016, By Volume (In Kilogram)
Figure 9: United Blood States Plasma Export to World, 2013-2016, By Value (In Billion)
Figure 10: China Blood Plasma Export to World, 2013-2016, By Volume (In Kilogram)
Figure 11: Worldwide Demand for factor VIII, By Volume (in IU)
Figure 12: Number of People With Bleeding Disorders, Worldwide, By Specific Disease, 2016
Figure 13: Number of People With Hemophilia, Worldwide, By Type, 2016
Figure 14: Usage of Factor VIII (IU Per Capita)*, 2016
Figure 15: Usage of Factor IX Per Capita (IU Per Capita)#, 2016
Figure 16: Number of People With Hemophilia, By Top 5 Countries, 2016
Figure 17: Number of Plasma Fractionation Plants, 2014
Figure 18: Capacity and Throughput of The Largest Fractionators ( In Thousand Liters)
Figure 19: Number of Prevalent Cases of COPD, Worldwide, 2015, (in thousands)
Figure 20: Number of Deaths By Alzheimer's Diseases and Other Dementias, By Selected Countries, 2016, (Per Million of Population)
Figure 21: Global Aged Population (Above 65), 2013-2017 (% of total)
Figure 22: Global Aged Population (Above 65), By Country, 2017 (% of total)
Figure 23: Healthcare Expenditure (Share of GDP), By Selected Country, 2013-2017 (In %)
Figure 24: Global Expected Healthcare Industry Outlook
Figure 25: Regional Expected Healthcare Industry Growth Rate By Year 2020
Figure 26: Key Factors Driving Global Healthcare Industry
Figure 27: Global Blood Plasma Market Size, By Value, Forecast, 2018-2023 (USD Billion)
Figure 28: Global Blood Plasma Market Share, By Company, 2017
Figure 29: Global Blood Plasma Market Size, By Type, 2017 (%)
Figure 30: Global Blood Plasma Market Size, By Type, 2023F (%)
Figure 31: Global Immunoglobulins Market, By Value, 2013-2017 (USD Billion)
Figure 32: Global Immunoglobulins Market, By Value,2018-2023(USD Billion)
Figure 33: Global Immunoglobulin Market, By Volume, 2013-2017, Volume (Tons)
Figure 34: Global Immunoglobulins Market, By Volume, 2018-2023(Tons)
Figure 35: Global IVIG Market Share, By Company, 2017
Figure 36: Global Albumin Market, By Value, 2013-2017 (USD Billion)
Figure 37: Global Albumin Market, By Value, 2018-2023 (USD Billion)
Figure 38: Global Albumin Market, By Volume, 2013-2017 (Tons)
Figure 39: Global Albumin Market, By Volume, 2018- 2023 (Tons)
Figure 40: Global Albumin Market Share, By Company, 2017
Figure 41: Global Factor VIII (Plasmatic), By Value, 2013-2017 (USD Billion)
Figure 42: Global Factor VIII (Plasmatic), By Value, 2018-2023 (USD Billion)
Figure 43: Global Factor VIII Market, By Volume, 2013-2017 (International Units)
Figure 44: Global Factor VIII Market, By Volume, 2018-2023 (International Units)
Figure 45: Global FVIII (Pd) Market Share, By Company, 2017
Figure 46: Other Plasma Products Market, By Value, 2013-2017 (USD Billion)
Figure 47: Other Plasma Products Market, By Value, 2018-2023 (USD Billion)
Figure 48: Market Comparison Chart, By Segments, 2013-2023 (USD Billion)
Figure 49: Global Market Attractiveness, By Segments, 2023F
Figure 50: Healthcare Industry Landscape, By Selected Region
Figure 51: North America Blood Plasma Market, By Value, 2013-2017 (USD Billion)
Figure 52: North America GDP per capita, current prices, 2013-2023F (In USD)
Figure 53: North America population aged 65 and above, 2013-2017 (% of total)
Figure 54: United States health care expenditure per capita,2013-2016(USD)
Figure 55: Canada health care expenditure per capita,2013-2016(USD)
Figure 56: North America Blood Plasma Market, By Value, 2018-2023 (USD Billion)
Figure 57: USA Blood Plasma Market, By Value, 2013-2017 (USD Billion)
Figure 58: USA Blood Plasma Market, By Value, 2018-2023(USD Billion)
Figure 59: U.S., Population ages 65 and above, 2013-2017 (% of total)
Figure 60: U.S. Blood Plasma Export To The World, 2015-2016, By Volume (In Kg)
Figure 61: United States health care expenditure,2013-2017(% of GDP)
Figure 62: Canada Blood Plasma Market, By Value, 2013-2017 (USD Billion)
Figure 63: Canada Blood Plasma Market, By Value, 2018-2023(USD Billion)
Figure 64: Canada, Expenditure on Health as a share of GDP, 2012-2017 (in %)
Figure 65: Canada, Population ages 65 and above, 2012-2017 (% of total)
Figure 66: Europe Blood Plasma Market, By Value, 2013-2017 (USD Billion)
Figure 67: Health Expenditure, By Select Country, 2016 (% of GDP)
Figure 68: Europe Population ages 65 years and above (% of total population), 2013-17
Figure 69: European Country Population Aged 65 and Above, 2012-2017 (% of Total)
Figure 70: GDP, Europe Region, By Select Country, 2017 (In Trillion USD)
Figure 71: Europe Blood Plasma Market, By Value, 2018-2023 (USD Billion)
Figure 72: Germany Blood Plasma Market, By Value, 2013-2017 (USD Billion)
Figure 73: Germany Blood Plasma Market, By Value, 2018-2023(USD Billion)
Figure 74: Germany, Population ages 65 and above, 2012-2017 (% total)
Figure 75: Germany, Health Expenditure Per Capita, PPP, 2012-2017 (USD)
Figure 76: France Blood Plasma Market, By Value, 2013-2017 (USD Billion)
Figure 77: France Blood Plasma Market, By Value, 2018-2023(USD Billion)
Figure 78: France, Population Ages 65 and Above, In total Population, 2013-2017
Figure 79: Italy Blood Plasma Market, By Value, 2013-2017 (USD Billion)
Figure 80: Italy Blood Plasma Market, By Value, 2018-2023(USD Billion)
Figure 81: Italy, Population Ages 65 and Above (% of total), 2013-2017
Figure 82: APAC & Oceania Blood Plasma Market, By Value, 2013-2017 (USD Billion)
Figure 83: GDP Per Capita in APAC, By Selected Country, 2013 (In USD)
Figure 84: GDP Per Capita in APAC, By Select Country, 2016 (In USD)
Figure 85: Population ages 65 and above, By Select Country, 2017 (% of total)
Figure 86: Population ages 65 and above, By Select Country, 2050 (% of total)
Figure 87: APAC & Oceania Blood Plasma Market, By Value, 2018-2023 (USD Billion)
Figure 88: China Blood Plasma Market, By Value, 2013-2017 (USD Billion)
Figure 89: China Blood Plasma Market, By Value, 2018-2023(USD Billion)
Figure 90: China, Total Population, 2013-17 (In Billion)
Figure 91: China, GDP Growth Per Year, 2015-2019F (In %)
Figure 92: China, Share of Urban Population, 2012-2017 (In %)
Figure 93: China, Share of Urban Population, 2012-2017 (In %)
Figure 94: Japan Blood Plasma Market, By Value, 2013-2017 (USD Billion)
Figure 95: Japan Blood Plasma Market, By Value, 2018-2023(USD Billion)
Figure 96: Japan, Consumption of IVIG, 2013-2017, (Million Vails/2.5g)
Figure 97: Plasma (Domestic Plasma) Through output by Japanese Fractionators, 2013-2017, Million Liters
Figure 98: Japan, Population ages 65 and above, 2012-2017 (% of total)
Figure 99: Japan Healthcare Expenditure Outlook (%)
Figure 100: India Blood Plasma Market, By Value, 2013-2017 (USD Billion)
Figure 101: India Blood Plasma Market, By Value, 2018-2023(USD Billion)
Figure 102: India, Population ages 65 and above, 2013-2017
Figure 103: India, Share of Urban Population, 2012-2017 (In %)
Figure 104: India, GDP Growth Per Year, 2015-2019 (In %)
Figure 105: India, Total Population, 2013-2023F (In Billion)
Figure 106: India, Health Expenditure Per Capita, PPP, 2012-2017 (USD)
Figure 107: India, Population ages 65 and above, 2012-2017 (% total)
Figure 108: Australia Blood Plasma Market, By Value, 2013-2017 (USD Billion)
Figure 109: Australia Blood Plasma Market, By Value, 2018-2023(USD Billion)
Figure 110: Australia, IG Demand, 2013- 2016 (Thousand Gram)
Figure 111: Australia, Source Plasma Collection Growth, 2013-2016 (%)
Figure 112: Australia, Population Above 65, 2013-2017 (% of Total)
Figure 113: Australia, Healthcare Expenditure, 2013- 2017 (% of GDP)
Figure 114: South-East Asia Blood Plasma Market, By Value, 2013-2017 (USD Billion)
Figure 115: South-East Asia Blood Plasma Market, By Value, 2018-2023(USD Billion)
Figure 116: Population Above 65, By Selected Southeast Asian Countries, 2017 (% of Total)
Figure 117: Healthcare Expenditure, By Selected Southeast Asian Countries, 2015 (% of GDP)
Figure 118: ROW Blood Plasma Market, By Value, 2013-2017 (USD Billion)
Figure 119: GDP Per Capita in ROW, By Select Country, 2013 (In USD)
Figure 120: GDP Per Capita in ROW, By Select Country, 2017 (In USD)
Figure 121: Population ages 65 and above, By Select Country, 2017 (% of total)
Figure 122: Population ages 60 or above, By Select Country, 2050 (% of total)
Figure 123: Latin America and Caribbean, Population ages 65 and above 2012-2017(% of total)
Figure 124: Latin America and Caribbean, Share of Urban Population in Total Population, 2012-2017 (In %)
Figure 125: Middle East and North Africa, Population ages 65 and above (% of total)
Figure 126: Middle East and North Africa, GDP, 2012-2017 (In USD Trillion)
Figure 127: ROW Blood Plasma Market, By Value, 2018-2023 (USD Billion)
Figure 128: Regional Market Comparison Chart, 2013-2023 (USD Billion)
Figure 129: Global Market Attractiveness, By Region, 2023F
Figure 130: Healthcare Expenditure (Share of GDP), By Selected Country, 2013-2017 (In %)
Figure 131: Global Aged Population(Above 65), (% of total)
Figure 132: Male population, 2013-2017 (In Billion)
Figure 133: Number of People With Dementia (In Million)
Figure 134: Grifols Plasma Fractionation Capacity Growth (In Million Litters)
Figure 135: CSL Limited Sales Revenue, Sales Revenue, 2013-2017 (USD Billion)
Figure 136: CSL Limited, Sales, By Business Segments, 2017 (In %)
Figure 137: CSL Limited, By Geographic Region, 2017 (In %)
Figure 138: Baxter International, Sales Revenue, Sales Revenue, 2013-2017 (USD Billion)
Figure 139: Baxter International, By Business Segments, 2017 (In %)
Figure 140: Baxter International, By Geographic Region, 2017 (In %)
Figure 141: Grifols S.A, Sales Revenue, Sales Revenue, 2013-2017 (USD Billion)
Figure 142: Grifols S.A, By Business Segments, 2017 (In %)
Figure 143: OCTA Pharma, Sales Revenue, Sales Revenue, 2013-2017 (USD Billion)
Figure 144: Emergent Bio-Solutions, Sales Revenue, Sales Revenue, 2013-2017 (USD Billion)
Figure 145: Emergent Bio-Solutions, By Geography, 2017 (In %)
Figure 146: Antaris Pharma, Sales Revenue, Sales Revenue, 2013-2017 (USD Billion)
Figure 147: AMAG Pharma, Sales Revenue, Sales Revenue, 2013-2017 (USD Billion)
Figure 148: Kedrion Bio Pharma, Sales Revenue, 2013-2017 (USD Billion)
Figure 149: Kedrion Bio Pharma, Sales Revenue, By Geography, 2017 (%)
Figure 150: Bio Delivery Science International, Sales Revenue, Sales Revenue, 2013-2017 (USD Billion)
Figure 151: Biotest A.G, Sales Revenue, Sales Revenue, 2013-2017 (USD Billion)
Figure 152: Biotest A.G, By Geography, 2017 (In %)